Cargando…
Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trial
BACKGROUND: The omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) and aspirin both have proof of concept for colorectal cancer chemoprevention, aligned with an excellent safety profile. Therefore, we aimed to test the efficacy of EPA and aspirin, alone and in combination and compared wi...
Autores principales: | Hull, Mark A, Sprange, Kirsty, Hepburn, Trish, Tan, Wei, Shafayat, Aisha, Rees, Colin J, Clifford, Gayle, Logan, Richard F, Loadman, Paul M, Williams, Elizabeth A, Whitham, Diane, Montgomery, Alan A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294731/ https://www.ncbi.nlm.nih.gov/pubmed/30466866 http://dx.doi.org/10.1016/S0140-6736(18)31775-6 |
Ejemplares similares
-
A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial
por: Hull, Mark A, et al.
Publicado: (2013) -
Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial
por: Davies, John R., et al.
Publicado: (2023) -
Promoting Independence in Dementia (PRIDE): A Feasibility Randomized Controlled Trial
por: Csipke, Emese, et al.
Publicado: (2021) -
Target trial emulation of aspirin after diagnosis of colorectal polyps
por: Emilsson, Louise, et al.
Publicado: (2023) -
Celecoxib use and circulating oxylipins in a colon polyp prevention trial
por: Martinez, Jessica A., et al.
Publicado: (2018)